Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.
about
The cancer stem cell: evidence for its origin as an injured autoreactive T cellHepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironmentFas and Fas ligand in gut and liver.Redirecting T cells to Ewing's sarcoma family of tumors by a chimeric NKG2D receptor expressed by lentiviral transduction or mRNA transfection.Cumulus cells accelerate oocyte aging by releasing soluble Fas ligand in mice.The TIMPs tango with MMPs and more in the central nervous system.Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma: indications of apoptotic tumor counterattack.The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.Regulation of apoptosis and proliferation in Ewing's sarcoma--opportunities for targeted therapy.Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.Adult human sarcomas. I. Basic science.Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.Apoptosis: why and how does it occur in biology?Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas.Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol proteinase (Streptococcus pyrogenic exotoxin B)Role of the Fas/Fas ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in HepG2 cells.Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells
P2860
Q25256839-4085D7AC-113C-40FB-81CD-8B6B388F6EEEQ28140022-C68671C7-515C-4FE7-8390-FD51ECA6CD2FQ33860215-56D28A1C-F9C9-4277-BA19-1EC44F644197Q34166288-E042EB2C-36B2-4E63-8B75-47E6877047CDQ35138707-A07BB0D1-A5F5-4614-8687-D5CE972D3CD9Q35613209-E38A3C5E-67BD-41C4-9904-EDD899C7DC4FQ35746752-8FF6CEEF-7A13-4699-B259-8CE17B691D46Q35782195-FB053A2B-84CD-4CDA-B3DB-1D1DE9397177Q36363792-0DC615B0-E111-4052-AD29-FCAB5B7382E9Q36622253-6F2AA1B5-ABAD-471F-B109-95F599961A62Q36691805-AC5AD8B2-3828-4781-B4A9-F198F8AD104FQ37012862-D8395B2B-0B77-4620-9E61-7C4CE565E490Q37902996-00EE348B-248E-4898-BFFB-7728C3641802Q40162839-7DC28D61-B047-4919-91E8-B33266E4F961Q40532231-C0470D70-53DA-44E1-9FD8-43CBAF1402C8Q40548794-DE1757FA-2ABD-456C-95C6-0818D638E0DCQ42004703-7ADDCAED-30FA-48A7-BBB9-5B7D6028C5C5
P2860
Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Fas ligand is present in tumor ...... e form by a metalloproteinase.
@ast
Fas ligand is present in tumor ...... e form by a metalloproteinase.
@en
type
label
Fas ligand is present in tumor ...... e form by a metalloproteinase.
@ast
Fas ligand is present in tumor ...... e form by a metalloproteinase.
@en
prefLabel
Fas ligand is present in tumor ...... e form by a metalloproteinase.
@ast
Fas ligand is present in tumor ...... e form by a metalloproteinase.
@en
P2093
P2860
P1476
Fas ligand is present in tumor ...... e form by a metalloproteinase.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65708-2
P407
P577
1998-12-01T00:00:00Z